Yasuo Seta

907 total citations
18 papers, 740 citations indexed

About

Yasuo Seta is a scholar working on Molecular Biology, Pharmaceutical Science and Biomaterials. According to data from OpenAlex, Yasuo Seta has authored 18 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Pharmaceutical Science and 6 papers in Biomaterials. Recurrent topics in Yasuo Seta's work include RNA Interference and Gene Delivery (10 papers), Dermatology and Skin Diseases (5 papers) and Advancements in Transdermal Drug Delivery (4 papers). Yasuo Seta is often cited by papers focused on RNA Interference and Gene Delivery (10 papers), Dermatology and Skin Diseases (5 papers) and Advancements in Transdermal Drug Delivery (4 papers). Yasuo Seta collaborates with scholars based in Japan and Finland. Yasuo Seta's co-authors include Takanori Kanazawa, Yuuki Takashima, Hisako Ibaraki, Hiroaki Okada, Toyofumi Suzuki, Hiroaki Okada, Tatu Lajunen, Arto Urtti, Marjo Yliperttula and Ko Tanaka and has published in prestigious journals such as Biomaterials, Molecules and International Journal of Pharmaceutics.

In The Last Decade

Yasuo Seta

18 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasuo Seta Japan 16 450 222 186 93 69 18 740
Hisako Ibaraki Japan 14 273 0.6× 160 0.7× 113 0.6× 60 0.6× 48 0.7× 19 480
Jie Niu China 13 364 0.8× 122 0.5× 156 0.8× 199 2.1× 51 0.7× 18 798
Liliana R. Pires Portugal 15 229 0.5× 163 0.7× 110 0.6× 94 1.0× 53 0.8× 19 563
Burçin Yavuz United States 17 259 0.6× 305 1.4× 247 1.3× 208 2.2× 28 0.4× 28 897
Zhicheng Le China 17 272 0.6× 172 0.8× 201 1.1× 266 2.9× 32 0.5× 30 833
Yang Chu China 7 233 0.5× 94 0.4× 93 0.5× 132 1.4× 29 0.4× 13 522
Tiejun Yuan China 12 303 0.7× 53 0.2× 101 0.5× 168 1.8× 28 0.4× 20 666
Anna Celli United States 19 353 0.8× 185 0.8× 50 0.3× 121 1.3× 58 0.8× 27 1.1k
Binghui Jin China 16 177 0.4× 89 0.4× 313 1.7× 240 2.6× 15 0.2× 22 766
Emma McErlean United Kingdom 9 229 0.5× 62 0.3× 139 0.7× 107 1.2× 45 0.7× 14 429

Countries citing papers authored by Yasuo Seta

Since Specialization
Citations

This map shows the geographic impact of Yasuo Seta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Seta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Seta more than expected).

Fields of papers citing papers by Yasuo Seta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuo Seta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Seta. The network helps show where Yasuo Seta may publish in the future.

Co-authorship network of co-authors of Yasuo Seta

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuo Seta. A scholar is included among the top collaborators of Yasuo Seta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuo Seta. Yasuo Seta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nishida, Shogo, et al.. (2023). A Multifunctional Hybrid Nanocarrier for Non-Invasive siRNA Delivery to the Retina. Pharmaceutics. 15(2). 611–611. 8 indexed citations
2.
Ibaraki, Hisako, et al.. (2021). Systemic delivery of siRNA to the colon using peptide modified PEG-PCL polymer micelles for the treatment of ulcerative colitis. European Journal of Pharmaceutics and Biopharmaceutics. 170. 170–178. 16 indexed citations
3.
4.
5.
Ibaraki, Hisako, Takanori Kanazawa, Hidemasa Nakaminami, et al.. (2020). The effects of surface properties of liposomes on their activity against Pseudomonas aeruginosa PAO-1 biofilm. Journal of Drug Delivery Science and Technology. 57. 101754–101754. 44 indexed citations
6.
7.
Ibaraki, Hisako, et al.. (2019). Anti-RelA siRNA-Encapsulated Flexible Liposome with Tight Junction-Opening Peptide as a Non-invasive Topical Therapeutic for Atopic Dermatitis. Biological and Pharmaceutical Bulletin. 42(7). 1216–1225. 37 indexed citations
8.
Ibaraki, Hisako, et al.. (2019). Effects of surface charge and flexibility of liposomes on dermal drug delivery. Journal of Drug Delivery Science and Technology. 50. 155–162. 43 indexed citations
9.
Ibaraki, Hisako, et al.. (2018). Transdermal anti-nuclear kappaB siRNA therapy for atopic dermatitis using a combination of two kinds of functional oligopeptide. International Journal of Pharmaceutics. 542(1-2). 213–220. 22 indexed citations
10.
Kanazawa, Takanori, Mami Kaneko, Hisako Ibaraki, et al.. (2017). Enhancement of nose-to-brain delivery of hydrophilic macromolecules with stearate- or polyethylene glycol-modified arginine-rich peptide. International Journal of Pharmaceutics. 530(1-2). 195–200. 48 indexed citations
11.
Kanazawa, Takanori, et al.. (2017). Intra-articular Retention and Anti-arthritic Effects in Collagen-Induced Arthritis Model Mice by Injectable Small Interfering RNA Containing Hydrogel. Biological and Pharmaceutical Bulletin. 40(11). 1929–1933. 14 indexed citations
12.
13.
Ibaraki, Hisako, Takanori Kanazawa, Yuuki Takashima, Hiroaki Okada, & Yasuo Seta. (2016). Development of an Innovative Intradermal siRNA Delivery System Using a Combination of a Functional Stearylated Cytoplasm-Responsive Peptide and a Tight Junction-Opening Peptide. Molecules. 21(10). 1279–1279. 18 indexed citations
14.
Kanazawa, Takanori, et al.. (2015). Functional peptide nanocarriers for delivery of novel anti-RelA RNA interference agents as a topical treatment of atopic dermatitis. International Journal of Pharmaceutics. 489(1-2). 261–267. 26 indexed citations
15.
16.
Lajunen, Tatu, Takanori Kanazawa, Hiroaki Okada, et al.. (2014). Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes. European Journal of Pharmaceutical Sciences. 62. 23–32. 79 indexed citations
17.
Tanaka, Ko, Takanori Kanazawa, Ken Sugawara, et al.. (2013). Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery. International Journal of Pharmaceutics. 455(1-2). 40–47. 44 indexed citations
18.
Kanazawa, Takanori, et al.. (2013). Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles. Biomaterials. 34(36). 9220–9226. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hisako Ibaraki Breakdown of academic impact, for papers by Jie Niu Breakdown of academic impact, for papers by Liliana R. Pires Breakdown of academic impact, for papers by Burçin Yavuz Breakdown of academic impact, for papers by Zhicheng Le Breakdown of academic impact, for papers by Yang Chu Breakdown of academic impact, for papers by Tiejun Yuan Breakdown of academic impact, for papers by Anna Celli Breakdown of academic impact, for papers by Binghui Jin Breakdown of academic impact, for papers by Emma McErlean
Rankless by CCL
2026